Angiogenesis is crucial for gynecologic cancer growth and metastasis. Targeting this process offers therapeutic potential. VEGF is a key driver, with anti-VEGF therapies showing clinical benefit. Resistance mechanisms…
This overview covers diverse aspects of gynecological screening, from updated cervical cancer guidelines emphasizing \textit{Human Papillomavirus} (HPV) testing and the impact of HPV vaccination, to the persistent…
vaccination is a pivotal strategy for preventing gynecologic cancers by targeting the human papillomavirus. It has demonstrated significant success in reducing HPV prevalence and precancerous lesions, leading to a…
Prognostic biomarkers are essential for personalizing treatment and improving outcomes in gynecologic cancers. Research focuses on molecular markers, ctDNA, TILs, molecular subtypes, HPV status, multi-omics, radiomics…
Robotic surgery is significantly advancing gynecologic oncology, offering enhanced precision, minimally invasive techniques, and improved patient outcomes for various cancers. It facilitates complex procedures with…
This review synthesizes recent advancements in gynecologic oncology, focusing on novel therapeutic strategies and their impact on patient outcomes. It highlights progress in immunotherapy, targeted therapies, and…
Genetic counseling plays a critical role in managing gynecologic cancers by identifying inherited predispositions through genetic testing and risk assessment. It guides personalized management strategies, including…
External beam radiotherapy (EBRT) and brachytherapy are cornerstones in managing gynecologic cancers, often combined with chemotherapy. Advanced techniques like IMRT and VMAT improve precision and reduce toxicity…
This collection of studies explores contemporary surgical advancements in gynecologic oncology. It details the growing prevalence of minimally invasive techniques, including robotic and laparoscopic surgery, for various…
This compilation reviews recent advancements in gynecological and breast imaging. It covers improved techniques for breast cancer detection using mammography, ultrasound, MRI, and AI. Ovarian imaging modalities…
Innovations in gynecologic tumor imaging are transforming diagnosis, staging, and treatment monitoring. MRI, CT, DWI, and CEUS enhance tissue characterization and early recurrence detection. PET/CT with
Epigenetic modifications are central to the initiation, progression, and therapeutic resistance of gynecologic cancers. DNA methylation and histone modifications alter gene expression, while ncRNAs are also…
Immunotherapy, especially immune checkpoint inhibitors (ICIs), is rapidly transforming gynecologic oncology, demonstrating efficacy in advanced ovarian, cervical, and endometrial cancers. Pembrolizumab has become a…
Recent studies highlight significant progress in gynecologic oncology. Niraparib and nivolumab show promise for advancedovarian cancer, with liquid biopsy enhancing early detection and monitoring. HPV vaccination…
This compilation of studies addresses the global epidemiology of gynecologic cancers, encompassing ovarian, cervical, endome trial, vulvar, and vaginal cancers. Insights from the Global Burden of Disease Study 2019…
This collection of research underscores rapid advancements in gynecologic oncology. It details progress in personalized medicine through molecular profiling and targeted therapies, including immune checkpoint inhibitors…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.